Perturbation of glycerol metabolism in hepatocytes from n3-PUFA-depleted rats

International Journal of Molecular Medicine

Volumn 29, Issue 6, 2012, Pages 1121-1126

  Portois, Laurence ^a   Zhang, Ying ^a   Ladrière, Laurence ^a   Perret, Jason ^a   Louchami, Karim ^a   Gaspard, Nathalie ^a   Hupkens, Emeline ^a   Bolaky, Nargis ^a   Delforge, Valérie ^a   Beauwens, Renaud ^a   Malaisse, Willy J ^a   Sener, Abdullah ^a   Carpentier, Yvon A ^a   Delporte, Christine ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Aquaglyceroporin; Glycerol kinase; Glycerol metabolism; Liver; Metabolic syndrome; Polyunsaturated fatty acids

Indexed keywords

AQUAGLYCEROPORIN; CARBON 14; GLYCEROL; GLYCEROL KINASE; MESSENGER RNA; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY LIVER; FEMALE; GLUCONEOGENESIS; HYPERTRIGLYCERIDEMIA; ISOTOPE LABELING; KNOCKOUT MOUSE; LIPID METABOLISM; LIVER CELL; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AQUAPORINS; CARBON RADIOISOTOPES; FATTY ACIDS, UNSATURATED; FEMALE; GENE EXPRESSION REGULATION; GLYCEROL; GLYCEROL KINASE; HEPATOCYTES; INTRACELLULAR SPACE; LIVER; MICE; PHOSPHOLIPIDS; RATS; RNA, MESSENGER; TIME FACTORS; TRIGLYCERIDES;

EID: 84860524302     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.943     Document Type: Article

References (40)

1. Jiamsripong P, Mookadam M, Honda T, Khandheria BK and Mookadam F: The metabolic syndrome and cardiovascular disease: Part I. Prev Cardiol 11: 155-161, 2008.
2. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM and Smith SC Jr: Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645, 2009.
3. Daram SR and Boppidi H: Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome. Postgrad Med 120: E01-E07, 2008.
4. Roche HM, Phillips C and Gibney MJ: The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc 64: 371-377, 2005. (Pubitemid 41160767)
5. Carpentier YA, Portois L and Malaisse WJ: n-3 Fatty acids and the metabolic syndrome. Am J Clin Nutr 83: S1499-S1504, 2006.
6. Barre DE: The role of consumption of alpha-linolenic, eicosapentaenoic and docosahexaenoic acids in human metabolic syndrome and type 2 diabetes - a mini-review. J Oleo Sci 56: 319-325, 2007.
7. Lombardo YB, Hein G and Chicco A: Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity. Lipids 42: 427-437, 2007. (Pubitemid 46870361)
8. Benatti P, Peluso G, Nicolai R and Calvani M: Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 23: 281-302, 2004. (Pubitemid 39096388)
9. Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56: 365-379, 2002.
10. Cancelas J, Prieto PG, Villanueva-Penacarrillo ML, Zhang Y, Portois L, Sener A, Carpentier YA, Valverde I and Malaisse WJ: Glucose intolerance associated to insulin resistance and increased insulin secretion in rats depleted in long-chain omega3 fatty acids. Horm Metab Res 39: 823-825, 2007. (Pubitemid 350206905)
11. Armitage JA, Pearce AD, Sinclair AJ, Vingrys AJ, Weisinger RS and Weisinger HS: Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency. Lipids 38: 459-464, 2003.
12. Peltier S, Malaisse WJ, Portois L, Demaison L, Novel-Chate V, Chardigny JM, Sebedio JL, Carpentier YA and Leverve XM: Acute in vivo administration of a fish oil-containing emulsion improves post-ischemic cardiac function in n-3-depleted rats. Int J Mol Med 18: 741-749, 2006.
13. Oguzhan B, Zhang Y, Louchami K, Courtois P, Portois L, Chardigny JM, Malaisse WJ, Carpentier YA and Sener A: Pancreatic islet function in omega3 fatty acid-depleted rats: Glucose metabolism and nutrient-stimulated insulin release. Endocrine 29: 457-466, 2006. (Pubitemid 44358836)
14. Oguzhan B, Sancho V, Acitores A, Villanueva-Penacarrillo ML, Portois L, Chardigny JM, Sener A, Carpentier YA and Malaisse WJ: Alteration of adipocyte metabolism in omega3 fatty acid-depleted rats. Horm Metab Res 38: 789-798, 2006. (Pubitemid 46051498)
15. Agre P: Aquaporin water channels (Nobel Lecture). Angew Chem Int Ed Engl 43: 4278-4290, 2004.
16. Verkman AS: Novel roles of aquaporins revealed by phenotype analysis of knockout mice. Rev Physiol Biochem Pharmacol 155: 31-55, 2005.
17. Krane CM and Goldstein DL: Comparative functional analysis of aquaporins/glyceroporins in mammals and anurans. Mamm Genome 18: 452-462, 2007. (Pubitemid 47360422)
18. Rojek A, Praetorius J, Frokiaer J, Nielsen S and Fenton RA: A current view of the mammalian aquaglyceroporins. Annu Rev Physiol 70: 301-327, 2008. (Pubitemid 351738182)
19. Hibuse T, Maeda N, Nagasawa A and Funahashi T: Aquaporins and glycerol metabolism. Biochim Biophys Acta 1758: 1004-1011, 2006. (Pubitemid 44373851)
20. Maeda N, Funahashi T and Shimomura F: Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat Clin Pract Endocrinol Metab 4: 627-634, 2008.
21. Verkman AS: Mammalian aquaporins: diverse physiological roles and potential clinical significance. Expert Rev Mol Med 10: e13, 2008.
22. Maeda N, Hibuse T and Funahashi T: Role of aquaporin-7 and aquaporin-9 in glycerol metabolism; involvement in obesity. Handb Exp Pharmacol 190: 233-249, 2009.
23. Rojek AM, Skowronski MT, Fuchtbauer EM, Fuchtbauer AC, Fenton RA, Agre P, Frokiaer J and Nielsen S: Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci USA 104: 3609-3614, 2007. (Pubitemid 46364206)
24. Simoens CH, Richelle M, Rössle C, Derluyn M, Deckelbaum RJ and Carpentier YA: Manipulation of tissue fatty acid profile by intravenous lipids in dogs. Clin Nutr 14: 177-185, 1995.
25. Soyfoo MS, De Vriese C, Debaix H, Martin-Martinez MD, Mathieu C, Devuyst O, Steinfeld SD and Delporte C: Modified aquaporin 5 expression and distribution in submandibular glands from NOD mice displaying autoimmune exocrinopathy. Arthritis Rheum 56: 2566-2574, 2007. (Pubitemid 47237275)
26. Seglen PO: Preparation of isolated rat liver cells. Methods Cell Biol 13: 29-83, 1976.
27. Liu GT, Zhang TM, Wang BE and Wang YW: Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol 43: 147-152, 1992.
28. Malaisse WJ: Alteration of pancreatic B-cell D-glucose metabolism in type-2 diabetes: The G quintet. Endocrinologia 40: 309-313, 1993.
29. Sancho V, Trigo MV, Gonzalez N, Valverde I, Malaisse WJ and Villanueva-Penacarrillo ML: Effects of glucagon-like peptide-1 and exendins on kinase activity, glucose transport and lipid metabolism in adipocytes from normal and type-2 diabetic rats. J Mol Endocrinol 35: 27-38, 2005. (Pubitemid 41167623)
30. Yilmaz MT, Sener A and Malaisse WJ: Glycerol phosphorylation and oxidation in pancreatic islets. Mol Cell Endocrinol 52: 251-256, 1987. (Pubitemid 17106985)
31. Bublitz C and Wieland O: Glycerokinase. Meth Enzym 5: 354-361, 1962.
32. Barrera LA and Ho R: Adipose glycerol kinase: low molecular weight protein has two Michaelis constants for glycerol. Biochem Biophys Res Commun 86: 145-152, 1979.
33. Kanoh H and Ohno K: Partial purification and properties of diacyl-glycerol kinase from rat liver cytosol. Arch Biochem Biophys 209: 266-275, 1981.
34. Kuriyama H, Shimomura I, Kishida K, Kondo H, Furuyama N, Nishizawa H, Maeda N, Matsuda M, Nagaretani H, Kihara S, et al: Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 51: 2915-2921, 2002.
35. Foss EJ, Radulovic D, Shaffer SA, Goodlett DR, Kruglyak L and Bedalov A: Genetic variation shapes protein networks mainly through non-transcriptional mechanisms. PLoS Biol 9: e1001144, 2011.
36. Huwiler A and Pfeilschifter J: Lipids as targets for novel anti-inflammatory therapies. Pharmacol Ther 124: 96-112, 2009.
37. Bordoni A, Di Nunzio M, Danesi F and Biagi PL: Polyunsaturated fatty acids: from diet to binding to PPARs and other nuclear receptors. Genes Nutr 1: 95-106, 2006.
38. Kishida K, Shimomura I, Kondo H, Kuriyama H, Makino Y, Nishizawa H, Maeda N, Matsuda M, Ouchi N, Kihara S, et al: Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel. J Biol Chem 276: 36251-36260, 2001.
39. Jiang YJ, Kim P, Lu YF and Feingold KR: PPARgamma activators stimulate aquaporin 3 expression in keratinocytes/epidermis. Exp Dermatol 20: 595-599, 2011.
40. McGilvery RW: Biochemistry: A Functional Approach. W.B. Saunders Company, Philadelphia, PA, p344, 1970.